Breaking News

Pillar5 Pharma Expands Operations

August 23, 2013

Receives $1M from Eastern Ontario Development Fund

Pillar5 Pharma, Inc. has received $1 million from the Eastern Ontario Development Fund (EODF) to expand production at its Arnprior manufacturing facility, creating 56 new jobs and retaining 94 more in the community.
With support from EODF, Pillar5 will increase its operations by installing two new, advanced production lines for the manufacturing and packaging of eye care products. This expansion will better position the company to pursue new markets, both at home and abroad.
Dr. Eric Hoskins, Minister of Economic Development, Trade and Employment, said, “We are proud to be supporting job creation right here in eastern Ontario. This investment will help Pillar5 become a leader in the production of eye care products while expanding their markets and bringing new jobs and prosperity to the community of Arnprior.”
Kevin Rampton, chief executive officer of Pillar5 Pharma, commented, “We are thankful for the support from the Ontario government. This expansion means we can offer our customers more solutions for their pharmaceutical outsourcing needs. It also gives us greater capacity to increase production and explore new markets.”

Related Contract Manufacturing:

Related Packaging:

Related Compliance:

blog comments powered by Disqus
  • The Role of Value in Drug Pricing

    The Role of Value in Drug Pricing

    Keren Shani, Ryan Million, Trinity Partners ||October 11, 2016
    Exploring the trend of using frameworks and models to evaluate the value of a drug

  • CRO-Sponsor Partnerships

    CRO-Sponsor Partnerships

    Craig Morgan, Brand Development Director, goBalto Inc.||October 11, 2016
    10 tips for enabling better CRO and sponsor collaborations

  • The Human Parts of Mouse Models

    The Human Parts of Mouse Models

    Julia Schueler, Head of in vivo Operations, Oncotest, a Charles River company ||October 11, 2016
    The PDX model system has come back into focus